IL-15, PeproTech 200-15-10UG from Thermo Fisher Scientific

Product Specs
ItemIL-15, PeproTech
CompanyThermo Fisher Scientific
Price Supplier Page
Catalog Number200-15-10UG
Storage-20°C
Formatno preservative
ApplicationsCell Culture
Size10UG
Molecule NameIL-15
TypeRecombinant
SpeciesHuman
NCBI Full Gene Nameinterleukin 15
NCBI Gene AliasesIL-15

Add to Compare List

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Krüppel-like factors 2 and 3 regulate T cell exhaustion by directing T cell residency and migrationImmunityMarch 27, 2026Jian Shen, Ryan J. Brown, Yuqi Zhang, Kexin Gai, Ashley K. Brown, Ashley M. Bauer, Ashley Zhu, Siying Lin, Hongshen Niu, Arjun Kharel, et al.IL-7,Thermo Fisher / PeproTech,Cat# 200-07-10UG Recombinant Human IL-15,Thermo Fisher / PeproTech,Cat# 200-15-10UG Recombinant Human IL-2,Thermo Fisher / PeproTech,Cat# 200-02-10UG Alt-R S.p. Cas9 Nuclease V3,IDT,Cat#

(2) Characterization of a pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionCancer CellJanuary 12, 2026Kenny Kwok Hei Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, Isabell Schulze, Jennifer Gantchev, Gerard Baquer, Kelsey Hopland, Evan D. Bander, Umberto Tosi, Cameron Brennan, et al."Human IL-2 Recombinant Protein, PeproTech®",Gibco,cat# 200-02-50UG "Human IL-15 Recombinant Protein, PeproTech®",Gibco,cat# 200-15-10UG Critical commercial assays,Critical commercial assays,Critical commercial assays Papain Dissociation System

(3) A role for Fas/FasL-dependent NK-mediated cytotoxicity in infants with perinatal HIViScienceNovember 21, 2025Akshay Iyer, Lesley de Armas, Vinh Dinh, Suresh Pallikkuth, Rajendra N. Pahwa, Paula Vaz, Maria Grazia Lain, Savita G. Pahwaproteins","Chemicals, peptides, and recombinant proteins" ,, Human recombinant IL-15,Peprotech,Cat# 200-15-10UG "CellTrace™ Violet Cell Proliferation Kit, for flow cytometry",ThermoFisher Scientific,Cat# C34557 Brefeldin

(4) CD9 antibody enhances the anti-leukemia efficacy of γδT cells in adult B cell acute lymphoblastic leukemiaiScienceNovember 21, 2025Yan Huang, Jingjing Wen, Luting Luo, Chenxing Zhao, Shaozhen Chen, Jiajie Yang, Wanying Liu, Changjian Yan, Yi Chen, Zhengjun Wu, et al.(hIL-2),Thermo Fisher Scientific,Cat#200-02-50UG Recombinant human IL-15 (hIL-15),Thermo Fisher Scientific,Cat#200-15-10UG Penicillin-Streptomycin solution,Shanghai Basalmedia Technologies,Cat#S110JV Puromycin,"Merck & Co.,

(5) Germline Neurofibromin 1 mutation enhances the anti-tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicityBritish journal of haematologyJuly 1, 2023Wang W, Li X, Qin X, Miao Y, Zhang Y, Li S, Yao R, Yang Y, Yu L, Zhu H, et al.

(6) EGFR as a potent CAR T target in triple negative breast cancer brain metastasesBreast cancer research and treatmentJanuary 1, 2023Subham S, Jeppson JD, Worcester C, Schatmeyer B, Zhao J, Madan R, Lakis NS, Kimler BF, McGuirk JP, Chen RC, et al.

(7) JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoidsJCI insightJune 8, 2022Nystrom SE, Li G, Datta S, Soldano KL, Silas D, Weins A, Hall G, Thomas DB, Olabisi OA.

(8) Disease-associated mutations in topoisomerase IIβ result in defective NK cellsThe Journal of allergy and clinical immunologyJune 1, 2022Broderick L, Clay GM, Blum RH, Liu Y, McVicar R, Papes F, Booshehri LM, Cowell IG, Austin CA, Putnam CD, et al.

(9) Orthotopic T-cell receptor replacement in primary human T cells using CRISPR-Cas9-mediated homology-directed repairSTAR protocolsMarch 18, 2022Moosmann C, Müller TR, Busch DH, Schober K.

(10) IL-6-induced FOXO1 activity determines the dynamics of metabolism in CD8 T cells cross-primed by liver sinusoidal endothelial cellsCell reportsFebruary 15, 2022Dudek M, Lohr K, Donakonda S, Baumann T, Lüdemann M, Hegenbarth S, Dübbel L, Eberhagen C, Michailidou S, Yassin A, et al.

(11) Epigenetic state determines inflammatory sensing in neuroblastomaProceedings of the National Academy of Sciences of the United States of AmericaFebruary 8, 2022Wolpaw AJ, Grossmann LD, Dessau JL, Dong MM, Aaron BJ, Brafford PA, Volgina D, Pascual-Pasto G, Rodriguez-Garcia A, Uzun Y, et al.

(12) Pyruvate metabolism guides definitive lineage specification during hematopoietic emergenceEMBO reportsFebruary 3, 2022Oburoglu L, Mansell E, Canals I, Sigurdsson V, Guibentif C, Soneji S, Woods NB.

(13) LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cellsHematological oncologyFebruary 1, 2022Matis S, Rossi M, Brondolo L, Cardillo M, Reverberi D, Massara R, Colombo M, Ibatici A, Angelucci E, Vaisitti T, et al.

(14) CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cellsNature communicationsJanuary 31, 2022Hebbar N, Epperly R, Vaidya A, Thanekar U, Moore SE, Umeda M, Ma J, Patil SL, Langfitt D, Huang S, et al.

(15) Engineered virus-like particles for efficient in vivo delivery of therapeutic proteinsCellJanuary 20, 2022Banskota S, Raguram A, Suh S, Du SW, Davis JR, Choi EH, Wang X, Nielsen SC, Newby GA, Randolph PB, et al.

(16) Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4⁺ T cells allows complex functional analysesNature methodsJanuary 1, 2022Albanese M, Ruhle A, Mittermaier J, Mejías-Pérez E, Gapp M, Linder A, Schmacke NA, Hofmann K, Hennrich AA, Levy DN, et al.

(17) HLA-A(∗)02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronavirusesCell reportsDecember 28, 2021Nesterenko PA, McLaughlin J, Tsai BL, Burton Sojo G, Cheng D, Zhao D, Mao Z, Bangayan NJ, Obusan MB, Su Y, et al.

(18) Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancerSTAR protocolsDecember 17, 2021Rotolo A, Atherton MJ, Kasper BT, Haran KP, Mason NJ.

(19) CD29 Enriches for Cytotoxic Human CD4(+) T CellsJournal of immunology (Baltimore, Md. : 1950)December 15, 2021Nicolet BP, Guislain A, Wolkers MC.

(20) Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALLMolecular therapy. Methods & clinical developmentDecember 10, 2021Deng B, Pan J, Liu Z, Liu S, Chen Y, Qu X, Zhang Y, Lin Y, Zhang Y, Yu X, et al.

Be the First to Write a Review!

FN

IL-15, PeproTech from Thermo Fisher Scientific

Thermo Fisher Scientific

Citations (349)

Reviews

IL-15, PeproTech from Thermo Fisher Scientific

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map